Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco Use (DuCATA_GAMCaT)

June 28, 2023 updated by: Cristina Martínez Martínez

Characterization of the Pattern of Consumption and Withdrawal Syndrome From Dual Cannabis and Tobacco Use in People With Cannabis Use Disorder Who Initiate Dishabituation Treatment (DuCATA_GAM-CAT)

Aims: To characterize the pattern of cannabis and tobacco use and withdrawal symptoms in people who start treatment for cannabis use disorders (exclusive cannabis, concurrent and/or simultaneous with various tobacco products) through an aplication game and considering the type of users. Methodology: Mixed-methods research composed of three studies. Study I: qualitative participatory action study aimed at exploring the experiences and preferences of the cannabis users on the use of apps. This information will be instrumental in the co-design of the app. Study II: prospective longitudinal study aimed to establish consumption patterns and transitions between substances and to validate the scale of cannabis withdrawal symptoms in the Spanish population. Sample size: expected RR=1.20, α =0.05, β= 0.20, losses= 20% (n=282). Study III: qualitative study to explore participants' experiences during the process of quitting cannabis and / or tobacco. Expected results: Characterization and prediction of variables that influence cannabis and tobacco cessation/ reduction and describe withdrawal symptoms according to consumption patterns with aim of improving the design of future interventions.

Study Overview

Study Type

Observational

Enrollment (Estimated)

282

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Smokers under treatment for cannabis substance abuse from the province of Barcelona in Catalonia (Spain)

Description

Inclusion Criteria:

  • Smokers (at least 1cig./week)
  • Undertreatment for Cannabis
  • >=18 years-old
  • Under clinical follow-up
  • Informed consent
  • Have a Smartphone

Exclusion Criteria:

  • Severe cognitive impairment
  • 3-month follow-up not guaranteed

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cannabis use
Time Frame: Change between baseline and 6 weeks follow-up
Number of participants that use several cannabis products (hashish, marijuana, etc.)
Change between baseline and 6 weeks follow-up
Tobacco use
Time Frame: Change between baseline and 6 weeks follow-up
Number of participants that use several type of tobacco product/s
Change between baseline and 6 weeks follow-up
Abstinence from cannabis
Time Frame: Change between baseline and 6 weeks follow-up
If a participant reduces or quits their cannabis use, we will ask for their presence of 16 withdrawal symptoms. Each symptom is scored from 0 (minimum) to 3 (maximum). Higher scores mean a worse outcome.
Change between baseline and 6 weeks follow-up
Abstinence from tobacco
Time Frame: Change between baseline and 6 weeks follow-up
If a participant reduces or quits their tobacco use, we will ask for their presence of 6 withdrawal symptoms using the Fagerström test. The test has a minimum score of 0 and a maximum of 10. Higher scores mean a worse outcome.
Change between baseline and 6 weeks follow-up

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Motivation to quit
Time Frame: Baseline
Using a Likert scale randing from 0 to 10 (0=totally unmotivated and 10= totally motivated)
Baseline
Psychological assessment
Time Frame: Baseline
States of change or readiness to quit cannabis and tobacco according to Prochaska and Di Clemente's model (pre-contemplative, contemplative, prepared, action and maintenance.
Baseline
Self-perceived health status
Time Frame: Baseline
Will be assessed based on "How would you say your general health is?" (excellent, very good, good, fair, very fair, poor)
Baseline
Social and cultural factors
Time Frame: Baseline
Questions related to their social circle/network (friends and colleagues) and social climate overall
Baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

July 1, 2023

Primary Completion (Estimated)

December 1, 2024

Study Completion (Estimated)

December 1, 2025

Study Registration Dates

First Submitted

May 6, 2022

First Submitted That Met QC Criteria

August 20, 2022

First Posted (Actual)

August 23, 2022

Study Record Updates

Last Update Posted (Actual)

July 3, 2023

Last Update Submitted That Met QC Criteria

June 28, 2023

Last Verified

June 1, 2023

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Tobacco Use

Subscribe